For a menopause-related search, choose a source category below. These categories also contain products for other uses; they are not a list of suitable treatments.
HORMONES AND SUBSTITUTES
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
SITAGLIPTIN: products 1 to 20 of 48.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Ach-Sitagliptin 100mg TabDIN 02512491 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Ach-Sitagliptin 25mg TabDIN 02512475 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Ach-Sitagliptin 50mg TabDIN 02512483 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Apo-Sitagliptin 100mg TabDIN 02428296 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Apo-Sitagliptin 25mg TabDIN 02428261 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Apo-Sitagliptin 50mg TabDIN 02428288 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Apo-Sitagliptin Malate 100mg TabDIN 02508672 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Apo-Sitagliptin Malate 25mg TabDIN 02508656 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Apo-Sitagliptin Malate 50mg TabDIN 02508664 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Auro-Sitagliptin 100mg TabDIN 02529882 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Auro-Sitagliptin 25mg TabDIN 02529866 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Auro-Sitagliptin 50mg TabDIN 02529874 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Jamp Sitagliptin 100mg TabDIN 02534150 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Jamp Sitagliptin 25mg TabDIN 02534134 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Jamp Sitagliptin 50mg TabDIN 02534142 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Januvia 100mg TabDIN 02303922 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Januvia 25mg TabDIN 02388839 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| Januvia 50mg TabDIN 02388847 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| M-Sitagliptin 100mg TabDIN 02535009 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
| M-Sitagliptin 25mg TabDIN 02534983 | General benefit | $0.8197per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
68:00 HORMONES AND SUBSTITUTES.
68:04 Corticosteroids.
68:08 Androgens.
68:12 Contraceptives.
68:16 Estrogens.
68:20:02 Oral Anti-Diabetic Agents.
68:20:06 Incretin Mimetics.
68:20:10 Insulins (Rapid Acting).
68:20:12 Insulins (Intermediate Acting).
68:20:14 Insulins (Long Acting).
68:20:16 Insulins (Pre-Mixed).
68:24 Parathyroid Agents.
68:28 Pituitary Agents.
68:32 Progestogens and Oral Contraceptives.
68:36 Thyroids.
68:38 Anti-Thyroids.
National Defence, WDH Guide to Menopause, 2026-09-17
Hormone Therapy (HT) previously called Hormone Replacement Therapy replaces estrogen and when needed, progesterone
Ontario Drug Benefit Formulary, Part V, 2026-09-03, p. 38
68:16 Estrogens
68:32 Progestogens and Oral Contraceptives